CAS 193153-04-7: Otamixaban
Description:Otamixaban is a synthetic small molecule that functions as a direct factor Xa inhibitor, primarily used in the context of anticoagulation therapy. It is characterized by its ability to selectively inhibit factor Xa, an essential enzyme in the coagulation cascade, thereby preventing thrombus formation. This compound is typically administered via intravenous routes and has been investigated for its potential in treating conditions such as acute coronary syndrome and during percutaneous coronary interventions. Otamixaban exhibits a relatively short half-life, which allows for rapid onset and offset of action, making it suitable for acute settings. Its pharmacokinetic profile includes high bioavailability and a predictable dose-response relationship, which are advantageous for clinical applications. Additionally, the safety profile of Otamixaban has been a focus of research, particularly concerning bleeding risks associated with anticoagulants. Overall, Otamixaban represents a significant advancement in anticoagulant therapy, offering a targeted approach to managing thrombotic disorders.
Formula:C25H26N4O4
InChI:InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1
InChI key:InChIKey=PFGVNLZDWRZPJW-OPAMFIHVSA-N
SMILES:O=C(OC)C(CC=1C=CC=C(C1)C(=N)N)C(NC(=O)C=2C=CC(=CC2)C3=CC=N(=O)C=C3)C
- Synonyms:
- Benzenepropanoic acid, 3-(aminoiminomethyl)-α-[(1R)-1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]-, methyl ester, (αR)-
- Benzenepropanoic acid, 3-(aminoiminomethyl)-α-[1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]-, methyl ester, [R-(R*,R*)]-
- Fxv-673
- Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate
- Otamixaban
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate REF: IN-DA00ABL5CAS: 193153-04-7 | 95% | To inquire | Fri 28 Mar 25 |
![]() | Otamixaban REF: 4Z-O-201CAS: 193153-04-7 | - - - | To inquire | Fri 04 Apr 25 |
![]() | Otamixaban REF: TM-T16410CAS: 193153-04-7 | 98.08% | 97.00 €~1,388.00 € | Fri 16 May 25 |
![]() | Otamixaban REF: 3D-THA15304CAS: 193153-04-7 | Min. 95% | - - - | Discontinued product |

Methyl (2R,3R)-2-[3-amidinobenzyl]-3-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]butanoate
Ref: IN-DA00ABL5
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |

Ref: 4Z-O-201
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

Otamixaban
Ref: TM-T16410
2mg | 284.00 € |

Otamixaban
Ref: 3D-THA15304
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |